Related Experiment Videos

Role of alpha(v) integrins in adenovirus cell entry and gene delivery

G R Nemerow1, P L Stewart

  • 1Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA. gnemerow@scripps.edu

Insights

Adenoviruses (Ad) are explored for gene therapy, leveraging their known structure and host cell interactions. Understanding Ad attachment and internalization receptors is key to improving Ad vectors for treating diseases.

Area of Science:

  • Virology
  • Gene Therapy
  • Molecular Biology

Background:

  • Adenoviruses (Ad) are common human pathogens, but replication-defective forms are investigated for gene therapy.
  • Ad vectors are used in 20-25% of gene therapy trials for inherited and acquired diseases.
  • Potential applications include cancer treatment and cardiovascular disease therapy.

Purpose of the Study:

  • To review the structure and function of Adenovirus attachment and internalization receptors.
  • To discuss the role of these receptors in Adenovirus infection and gene delivery.
  • To highlight recent structural studies and identify future research directions for improving Adenovirus vectors.

Main Methods:

  • Review of existing literature on Adenovirus structure, genome, replication, and host cell interactions.
  • Analysis of studies on Adenovirus attachment (coxsackievirus and Ad receptor [CAR]) and internalization (alpha(v) integrins) receptors.
  • Inclusion of recent cryoelectron microscopy studies on integrin-Adenovirus complexes.

Main Results:

  • Adenoviruses utilize specific receptors, including CAR for attachment and alpha(v) integrins for internalization, which dictate virus tropism.
  • Extensive knowledge of Adenovirus structure and replication facilitates vector development.
  • Cryoelectron microscopy provides detailed insights into integrin-Adenovirus interactions.

Conclusions:

  • Understanding Adenovirus-receptor interactions is crucial for optimizing Adenovirus vectors for gene therapy.
  • Further research into these interactions can address current limitations and enhance vector efficacy.
  • Targeting specific receptors holds promise for improving Adenovirus-mediated gene delivery in future therapeutic applications.

Related Concept Videos